Estrella Immunopharma, Inc. (ESLAW) dividend history
ESLAWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLA
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.09+0.02 (+25.07%)
Close on Nov 13, 2026Market cap $22.36MP/E –Yield –
Dividends
Estrella Immunopharma has not reported a dividend
No dividend per share appears in Estrella Immunopharma's annual filings since fiscal 2020.
See a number that looks wrong?